Search research articles
Contact Us
Filters
Showing results (161-170 of 178) with videos related to
Page
of 18
Sort By:
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
December 30, 2020
[The Breast Cancer Cohort Study in Chinese Women: the methodology of population-based cohort and baseline characteristics]
H L Bao, L Y Liu, L W Fang, et al.
Blood Cancer Journal
|
July 29, 2017
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
H-A Hou, J-W Lu, T-Y Lin, et al.
Leukemia
|
February 20, 2009
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients
W-C Chou, C-Y Chen, H-A Hou, et al.
British Journal of Cancer
|
September 1, 2011
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
C-L Cheng, H-A Hou, J-Y Jhuang, et al.
Leukemia
|
August 30, 2008
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
J Cortes, D-W Kim, E Raffoux, et al.
Leukemia
|
November 17, 2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
W-C Chou, W-C Lei, B-S Ko, et al.
Blood Cancer Journal
|
August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution
H-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia
|
April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
C-H Tsai, H-A Hou, J-L Tang, et al.
Blood Cancer Journal
|
January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome
T-C Chen, H-A Hou, W-C Chou, et al.
Leukemia
|
August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
H A Hou, C C Lin, W C Chou, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 178) with videos related to
Sort By:
Page
of 18
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
December 30, 2020
[The Breast Cancer Cohort Study in Chinese Women: the methodology of population-based cohort and baseline characteristics]
H L Bao, L Y Liu, L W Fang, et al.
Blood Cancer Journal
|
July 29, 2017
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
H-A Hou, J-W Lu, T-Y Lin, et al.
Leukemia
|
February 20, 2009
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients
W-C Chou, C-Y Chen, H-A Hou, et al.
British Journal of Cancer
|
September 1, 2011
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
C-L Cheng, H-A Hou, J-Y Jhuang, et al.
Leukemia
|
August 30, 2008
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
J Cortes, D-W Kim, E Raffoux, et al.
Leukemia
|
November 17, 2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
W-C Chou, W-C Lei, B-S Ko, et al.
Blood Cancer Journal
|
August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution
H-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia
|
April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
C-H Tsai, H-A Hou, J-L Tang, et al.
Blood Cancer Journal
|
January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome
T-C Chen, H-A Hou, W-C Chou, et al.
Leukemia
|
August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
H A Hou, C C Lin, W C Chou, et al.
Page
of 18